PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)

NCT00536263 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

671

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: pegylated interferon alpha-2b
DRUG: pegylated interferon alpha-2b
DRUG: pegylated interferon alpha-2b

Sponsor

Merck Sharp & Dohme LLC